These final results, along with a preceding report displaying that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,2 support the notion of concentrating on ACKR3 as a novel approach to modulate the opioid process, which could open up new therapeutic avenues for opioid-associated disorders. Helps to reduce https://billp314gdy3.blue-blogs.com/profile